RxDoctor Payments Data

Arthur Rabinowitz, MD

Cardiovascular Disease · Billings, MTNPI 1780638148

Payments from drug & device makers

What this record shows

Medtronic accounts for 65.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $770 and has fallen 92.6% since, to $57 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in MT, where the typical reported total is $1,321.

$1,322in general payments, 2019–2025

Across 19 payments — averaging $69.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$860
  • Abiomed$232
  • Biosense Webster, Inc.$65
  • Boston Scientific$52
  • Abbott$46
  • Boehringer Ingelheim$35
  • plus $31 from 2 others
$500in research payments, 2019–2025

Across 4 payments — averaging $125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$500

What the payments were for

  • Travel & lodging$77058%
  • Food & beverage$55242%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,322 in reported general payments places this provider in the 50th percentile of 49 cardiovascular disease providers in Montana.

See all cardiovascular disease providers in Montana

Medicare billing

Part B allowed, 2024
$112,644
Medicare patients
276
Services billed
672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate20$172
Atorvastatin Calcium18$48

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Billings

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →